ALPHA TRIBE

Windlas Biotech LimitedBoard Meeting, 06-11-2025: Outcome of Board Meeting

06-11-2025 | 06:26 pm

Windlas Biotech's Board has approved the financial results for the quarter and half-year. Consolidated Q2 revenue reached ₹222.40 Cr with a profit of ₹17.80 Cr. Half-year revenue was ₹432.49 Cr, posting a profit of ₹35.46 Cr.

No comments yet. Be the first to comment!

All announcements from Windlas Biotech Limited